Notice of Shandong Buchang Pharmaceutical Co., Ltd. on convening the 2025 Annual Shareholders Meeting
Securities code: 603858 Securities abbreviation: Buchang Pharmaceutical Announcement number: 2026-074 Shandong Buchang Pharmaceutical Co., Ltd.
Notice on Convening the 2025 Annual Shareholders Meeting
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Date of shareholders’ meeting: June 26, 2026
The online voting system adopted for this shareholders’ meeting: Shanghai Stock Exchange Shareholders’ Meeting Online Voting System
1. Basic information on convening the meeting
(1) Type and session of shareholders’ meeting:
2025 Annual Shareholders Meeting
(2) Convener of shareholders’ meeting: Board of Directors
The company issued a notice for the 49th meeting of the fifth board of directors on May 14, 2026, and it was held by communication at 13:00 on May 25, 2026. The meeting reviewed and approved the "Proposal on Convening the 2025 Annual Shareholders Meeting" with a voting result of 12 votes in favor, 0 votes against, and 0 abstentions.
(3) Voting method: The voting method used in this shareholders’ meeting is a combination of on-site voting and online voting.
(4) Date, time and place of on-site meeting
Date and time of convening: 13:00 on June 26, 2026
Venue: Conference Room, No. 1566, Zhonghua West Road, Heze City, Shandong Province
(5) Online voting system, start and end dates and voting time.
Online voting system: Shanghai Stock Exchange Shareholders Meeting online voting system
Online voting start and end time: from June 26, 2026 to June 26, 2026
Using the Shanghai Stock Exchange's online voting system, the voting time through the trading system voting platform is the trading time period on the day the shareholders' meeting is held, that is, 9:15-9:25, 9:30-11:30, 13:00-15:00; the voting time through the Internet voting platform is 9:15-15:00 on the day the shareholders' meeting is held.
(6) Voting procedures for margin financing and securities lending, refinancing, agreed repurchase business accounts and Shanghai-Hong Kong Stock Connect investors
Voting involving accounts related to margin financing and securities lending, refinancing business, agreed repurchase business, and Shanghai-Hong Kong Stock Connect investors shall be implemented in accordance with the "Shanghai Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations" and other relevant regulations.
(7) Involving the public solicitation of shareholder voting rights:
Not involved
2. Matters to be considered at the meeting
The resolutions to be reviewed and the types of voting shareholders at this shareholders’ meeting
Voting shareholder type serial number Proposal name
Non-cumulative voting resolution for A-share shareholders
1 Proposal on the company's 2025 board of directors work report √ 2 Proposal on the company's 2025 independent director's performance report √ 3 Proposal on the company's 2025 financial final accounts √ 4 Proposal on the company's 2026 financial budget √ 5 Proposal on the company's 2025 annual report and summary √ 6 Proposal on the company's 2025 final profit distribution √ 7 Regarding the company's renewal in 2026 Proposal from the accounting firm in 2016 √
Regarding the actual amount of daily related transactions of the company in 2025 and 2026
8 √
Anticipated daily related transaction proposals
Special project on the deposit and actual use of funds raised by the company in 2025
9 √
reported motion
10 Proposal on providing financial assistance to holding subsidiaries in 2026 √
Regarding the review of the expected financing amounts and guarantees of the company and its holding subsidiaries in 2026
11√
Proposal on insurance amount
12 Proposal on the Company’s Provision for Asset Impairment and Recognition of Changes in Fair Value √ 13 Proposal on Amending the Articles of Association of Shandong Buchang Pharmaceutical Co., Ltd. √
Regarding the formulation of "Directors and Senior Managers of Shandong Buchang Pharmaceutical Co., Ltd.
14√
Proposal on the Employee Remuneration Management System
15 Proposal on the 2026 remuneration plan for the company’s directors and senior managers √ 16 Proposal on the company’s 2026 interim dividend arrangement √
- The time and disclosure media of each proposal
Each proposal has been reviewed and approved at the 47th (annual) meeting of the fifth board of directors held by the company on April 27, 2026. For details, please refer to the company’s relevant announcements on the Shanghai Stock Exchange website (www.sse.com.cn) and the designated information disclosure media "China Securities Journal", "Shanghai Securities News", "Securities Times" and "Securities Daily" on April 28, 2026. The company will disclose the shareholders' meeting materials containing all resolutions on the website of the Shanghai Stock Exchange before the shareholders' meeting.
Special resolutions: 11, 13
Proposals for separate counting of votes for small and medium investors: 6, 7, 8, 9, 10, 15, 16
Proposals involving related shareholders’ avoidance of voting: 8, 15
Names of related shareholders who should avoid voting: Buchang (Hong Kong) Holdings Co., Ltd., Shoucheng International (Hong Kong) Co., Ltd., Tibet Danhong Enterprise Management Co., Ltd., Tibet Ruixing Investment Consulting Co., Ltd., Tibet Guangfa Investment Consulting Co., Ltd., and Tibet Hualian Business Information Consulting Co., Ltd.
- Proposals involving preference shareholders’ participation in voting: None
3. Things to note when voting at the shareholders’ meeting
(1) The shareholders of the Company who exercise their voting rights through the online voting system of the Shanghai Stock Exchange’s shareholders’ meeting can either log in to the trading system voting platform (through the trading terminal of the securities company designated for trading) to vote, or log in to the Internet voting platform (website: vote.sseinfo.com) to vote. When logging into the Internet voting platform to vote for the first time, investors need to complete shareholder identity authentication. For specific operations, please see the instructions on the Internet voting platform website.
In order to better serve the majority of small and medium-sized investors, we ensure that small and medium-sized investors who are willing to vote can participate in the meeting and vote in a timely manner. The company plans to use the reminder service (i.e. "one-click call") provided by SSE Information Network Co., Ltd. to proactively remind shareholders to participate in the meeting and vote based on the shareholder list on the equity registration date through smart text messages and other forms, and proactively push meeting invitations, proposal status and other information to each investor. After receiving the smart text message, investors can vote directly according to the prompts in the "User Manual of One-Click Online Voting Service for Listed Company Shareholders Meetings" (download link: https://vote.sseinfo.com/i/yjt_help.pdf). In case of congestion, etc., they can still vote through the original trading system voting platform and Internet voting platform.
(2) For a shareholder holding multiple shareholder accounts, the number of exercisable voting rights is the total number of common shares of the same category and preference shares of the same variety held by all shareholder accounts under his or her name.
Shareholders holding multiple shareholder accounts who participate in online voting at the shareholders' meeting through the Exchange's online voting system can participate through any of their shareholder accounts. After the voting, it shall be deemed that all ordinary shares of the same category and preferred shares of the same variety under all shareholder accounts have voted with the same opinion.
If a shareholder holding multiple shareholder accounts votes repeatedly through multiple shareholder accounts, the voting opinions of the same class of ordinary shares and the same type of preferred stocks under all shareholder accounts shall be based on the first voting results of each class and type of stocks respectively.
(3) If the same voting right is voted on repeatedly through on-site, online voting platform of the Exchange or other methods, the result of the first vote shall prevail.
(4) Shareholders must vote on all proposals before they can be submitted.
4. Participants at the meeting
(1) Shareholders of the company who are registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. at the market close in the afternoon on the equity registration day have the right to attend the shareholders’ meeting (see the table below for details), and may entrust a proxy in writing to attend the meeting and participate in voting. The agent does not have to be a shareholder of the company.
Share class Stock code Stock abbreviation Equity registration date
A shares 603858 Buchang Pharmaceutical 2026/6/23
(2) Directors and senior managers of the company.
(3) Lawyers hired by the company.
(4) Other personnel
5. Meeting registration method
(1) Registration method:
Natural person shareholders: must present their ID card and shareholding certificate for registration; those who authorize an agent to attend the meeting must present their ID card, power of attorney and the principal's shareholding certificate for registration;
Legal person shareholders: If the legal representative attends the meeting, he or she must present a copy of the business license, identity certificate of the legal representative and shareholding certificate for registration; if an agent entrusted by the legal representative attends the meeting, he/she must register with his/her identity card, copy of the business license, power of attorney and shareholding certificate;
Shareholders from other places can register by written letter or email ([email protected]), but when attending the on-site meeting, they should bring the originals of the above documents for inspection. Postal code: 274000. (Please indicate the words "Shareholders Meeting" on the letter)
(2) Registration time: June 26, 2026
(3) Registration location: Conference Room, No. 1566, Zhonghua West Road, Heze City, Shandong Province
6. Other matters
- Contact information:
Contact: Hao Jingfang, Dong Xiaoqian, Wang Lu
Tel: 18729276000 (Hao Jingfang)
15891396548 (Dong Xiaoqian)
13720547527 (Wang Lu)
Participating shareholders (in person or by proxy) are responsible for their own round-trip transportation and accommodation expenses to attend the shareholders' meeting.
Participating shareholders should arrive at the meeting site half an hour in advance to sign in. Announcement is hereby made.
Board of Directors of Shandong Buchang Pharmaceutical Co., Ltd.
Attachment 1 on May 26, 2026: Power of Attorney
Attachment 1: Power of attorney
Power of attorney
Shandong Buchang Pharmaceutical Co., Ltd.:
I hereby authorize Mr. (Ms.) to attend the 2025 Annual Shareholders Meeting of your company to be held on June 26, 2026 on behalf of the unit (or myself), and to exercise voting rights on my behalf.
Number of common shares held by the client:
Number of preferred shares held by the client:
Client shareholder account number:
Serial number Name of non-cumulative voting proposal Agree Oppose Abstain Recusal 1 Proposal on the company’s 2025 annual board of directors work report
2 Proposal on the Company’s 2025 Independent Directors’ Performance Report 3 Proposal on the Company’s 2025 Financial Final Accounts
4 Proposal on the company’s 2026 financial budget
5 Proposal on the company’s 2025 annual report and summary
6 Proposal on the company’s final profit distribution in 2025
7 Proposal on the Company’s Re-appointment of the Accounting Firm in 2026
Proposal on the actual amount of daily related transactions of the company in 2025 and the expected daily related transactions in 2026
Regarding the deposit and actual use of funds raised by the company in 2025
special report proposal
10 Proposal on providing financial assistance to controlled subsidiaries in 2026 11 Proposal on reviewing the expected financing and guarantee limits of the company and its controlled subsidiaries in 2026
Proposal on the Company's Provision for Asset Impairment and Recognition of Changes in Fair Value
Proposal on Amending the Articles of Association of Shandong Buchang Pharmaceutical Co., Ltd.
Proposal on formulating the "Remuneration Management System for Directors and Senior Management of Shandong Buchang Pharmaceutical Co., Ltd."
Proposal on the 2026 remuneration plan for the company’s directors and senior managers
16 Proposal on the company’s 2026 interim dividend arrangement
Signature (stamped) of the principal: Signature of the trustee:
Trustee’s ID number: Trustee’s ID number:
Commission date: year month day
Remarks:
The client should choose one of the "agree", "objection", "abstain" or "avoidance" intentions in the power of attorney and tick "√". If the client does not give specific instructions in this power of attorney, the trustee has the right to vote according to his own wishes.